Clinical data | |
---|---|
Other names | 5-TFM-DMT |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
Chemical and physical data | |
Formula | C13H15F3N2 |
Molar mass | 256.272 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
5-TFM-DMT (5-(trifluoromethyl)-DMT, 5-CF3-DMT, 5-(trifluoromethyl)-N,N-dimethyltryptamine) is a putative psychedelic tryptamine derivative related to drugs such as 5-MeO-DMT, 5-Fluoro-DMT, and 5-TFMO-DMT. It acts as a partial agonist at the 5-HT2A receptor, with an EC50 of 185.7 nM and an efficacy of 28.7% (vs 5-HT), and a full agonist at 5-HT2C with an EC50 of 89.7 nM and an efficacy of 88.8%, and no significant activity at 5-HT2B.
See also
References
Tryptamines | |
---|---|
Tryptamines |
|
N-Acetyltryptamines |
|
α-Alkyltryptamines |
|
Triptans | |
Cyclized tryptamines |
|
Isotryptamines | |
Related compounds |
|
This hallucinogen-related article is a stub. You can help Misplaced Pages by expanding it. |